Stay updated on Lanadelumab for Pediatric HAE Attacks Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab for Pediatric HAE Attacks Clinical Trial page.

Latest updates to the Lanadelumab for Pediatric HAE Attacks Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedA new revision, v3.6.3, was added, replacing the previous v3.6.2. This reflects an update to the page's record history.SummaryDifference0.1%

- Check24 days agoChange DetectedA new revision label v3.6.2 has been added to the record history, replacing the older v3.6.0 entry. This reflects an updated site release in the page's version history.SummaryDifference0.1%

- Check38 days agoChange DetectedThe history now indicates recruitment has closed (no longer looking for participants). A new revision tag v3.6.0 was added and the previous revision tag v3.5.5 was removed.SummaryDifference0.4%

- Check45 days agoChange DetectedThe history now lists Revision: v3.5.5, replacing the previous v3.5.4. This marks a new revision of the page's documentation within ClinicalTrials.gov.SummaryDifference0.1%

- Check66 days agoChange DetectedThe history updates to include a new site revision, v3.5.4, while the previous revision, v3.5.3, is removed from the record. This reflects a version bump in the site's release notes.SummaryDifference0.1%

- Check81 days agoChange DetectedA new page revision label, v3.5.3, was added and the previous v3.5.2 label was removed. This reflects an update to the page's version history metadata rather than changes to the study content.SummaryDifference0.1%

Stay in the know with updates to Lanadelumab for Pediatric HAE Attacks Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab for Pediatric HAE Attacks Clinical Trial page.